Bridgefront Capital’s Mersana Therapeutics MRSN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-625	Closed	-$97K	–	373
2021 Q4	$97K	Buy	+625	New	+$97K	0.09%	272
2021 Q3	–	Sell	-449	Closed	-$153K	–	559
2021 Q2	$153K	Buy	+449	New	+$153K	0.06%	529